Multidrug-resistant tuberculosis in Iran: a multicenter study
Open Access
- 12 January 2024
- journal article
- research article
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
Abstract
The worldwide incidence of multi-drug-resistant tuberculosis (MDR-TB) is rapidly increasing, and it has emerged as a pressing public health issue in Iran. Nevertheless, there is a scarcity of up-to-date research on the prevalence of MDR-TB in individuals with pulmonary TB in the country. In this cross-sectional study, we gathered a total of 1216 respiratory samples, each corresponding to a unique patient, from five distinct regional TB laboratories in Iran. We identified clinical isolates as Mycobacterium tuberculosis using the IS6110-based PCR assay and Xpert MTB/RIF. Drug susceptibility testing (DST) was conducted using the conventional proportion method. Out of the collected specimens, 448 tested positive for M. tuberculosis. Among these isolates, 445 (99.4%) exhibited susceptibility to the tested drugs, while 3 (0.6%) were found to be MDR. The findings from this recent study indicate that the prevalence of MDR in Iran stands at 0.6%. The absence of recently approved treatment protocols in various regions of Iran, along with inadequately equipped laboratories lacking DST capabilities, could contribute significantly to the rise in TB/MDR-TB prevalence in Iran. Therefore, the implementation of enhanced treatment management strategies and the adoption of innovative technologies are essential steps towards improving the current situation.Keywords
This publication has 32 references indexed in Scilit:
- Direct drug susceptibility testing of Mycobacterium tuberculosis using the proportional method: A multicenter studyJournal of Global Antimicrobial Resistance, 2019
- New drugs and perspectives for new anti-tuberculosis regimens ☆Pulmonology, 2018
- Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest IranNew Microbes and New Infections, 2017
- Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectivesClinical Microbiology and Infection, 2017
- Multidrug resistant tuberculosisBMJ, 2015
- Prevalence of drug-resistant tuberculosis in Iran: Systematic review and meta-analysisAmerican Journal of Infection Control, 2014
- Drug resistance pattern of Mycobacterium tuberculosis isolates from patients of five provinces of IranAsian Pacific Journal of Tropical Medicine, 2014
- Anti tuberculosis drug resistance in west of IranJournal of Global Infectious Diseases, 2014
- Cost-Effectiveness of Treating Multidrug-Resistant TuberculosisPLOS Medicine, 2006
- Drug-susceptibility testing in tuberculosis: methods and reliability of resultsEuropean Respiratory Journal, 2005